Latest Insider Transactions at Mylan N.V. (MYL)
This section provides a real-time view of insider transactions for Mylan N.V. (MYL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Mylan N.V. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Mylan N.V.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 16
2020
|
Paul Campbell Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
826
-100.0%
|
-
|
Nov 16
2020
|
Paul Campbell Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
30,336
-100.0%
|
-
|
Nov 16
2020
|
Sjoerd S Vollebregt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
57,709
-100.0%
|
-
|
Nov 16
2020
|
Sjoerd S Vollebregt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,440
+14.06%
|
-
|
Nov 16
2020
|
Meer Mohr Pauline Van Der Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,265
-100.0%
|
-
|
Nov 16
2020
|
Richard A Mark Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,228
-100.0%
|
-
|
Nov 16
2020
|
Harry Korman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
26,515
-100.0%
|
-
|
Nov 16
2020
|
Randall L Vanderveen Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
57,227
-100.0%
|
-
|
Nov 16
2020
|
Randall L Vanderveen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,440
+14.16%
|
-
|
Nov 16
2020
|
Rajiv Malik President |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
88,365
-100.0%
|
-
|
Nov 16
2020
|
Rajiv Malik President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
459,699
-100.0%
|
-
|
Nov 16
2020
|
Melina E Higgins Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
74,000
-100.0%
|
-
|
Nov 16
2020
|
Melina E Higgins Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
39,131
-100.0%
|
-
|
Nov 16
2020
|
Anthony Mauro Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
5,574
-100.0%
|
-
|
Nov 16
2020
|
Anthony Mauro Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
119,305
-100.0%
|
-
|
Nov 16
2020
|
Neil F Dimick Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
51,263
-100.0%
|
-
|
Nov 16
2020
|
Dillon Jo Ellen Lyons Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,609
-100.0%
|
-
|
Nov 16
2020
|
Robert J Cindrich Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
35,165
-100.0%
|
-
|
Nov 16
2020
|
Robert J Cindrich Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,440
+21.16%
|
-
|
Nov 16
2020
|
Robert J Coury Executive Chairman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,383,587
-100.0%
|
-
|
Nov 16
2020
|
Mark W Parrish Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
58,295
-100.0%
|
-
|
Nov 16
2020
|
Heather M Bresch Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,157
-100.0%
|
-
|
Nov 16
2020
|
Heather M Bresch Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
580,642
-100.0%
|
-
|
Mar 23
2017
|
Laboratories Abbott > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
44,000,000
-63.08%
|
$1,804,000,000
$41.6 P/Share
|